Abstract
Descemet membrane endothelial keratoplasty (DMEK) is the closest to the physiological replacement of endothelial cells. In the initial years, the technique was surgically challenging. Over the years, with better understanding and modifications in the surgical steps, the technique has evolved as an alternative to more popular procedure Descemet stripping endothelial keratoplasty. The article highlights the various preoperative, intraoperative, and postoperative nuances of DMEK. Additionally, it summarizes the various comparative and noncomparative studies on DMEK outcomes.
Keywords: DMEK outcomes, preoperative, postoperative nuances
In the last few decades, keratoplasty has evolved from full-thickness corneal transplantation to selective corneal transplantation. The endothelial keratoplasty (EK) evolved from posterior lamellar keratoplasty to Descemet stripping endothelial keratoplasty (DSEK), Descemet stripping automated endothelial keratoplasty (DSAEK), Ultrathin DSAEK, Descemet membrane endothelial keratoplasty (DMEK), and direct cultured endothelial cell injection therapy.[1] Although direct cultured endothelial cell injection therapy is the most specific treatment for endothelial diseases, it needs a larger multicenteric trial on human eyes to prove its efficacy and reproducibility.[2,3] Currently, the most physiological way to replace diseased endothelium is DMEK. This review focuses on surgical nuances involved in DMEK and their outcomes.
Relevance of DMEK in Current Scenario
Among various options to treat endothelial disorders, DSEK is more popular one due to the simplicity of the surgical procedure, easier learning curve, more versatile applications, and nonrestriction of donor age criteria. DMEK allows for a nearly exact anatomical replacement of abnormal endothelial layer has an advantage of more predictable refractive outcomes and lesser risk of allograft rejection in view of lower antigenic load of the lamellar graft. Further, due to the characteristics of Descemet membrane (DM) roll and nature of the surgery, the technique has generated renewed interest in donors of older age. With these advantages of DMEK, it has become a procedure of choice in several indications for EK.
The current review addresses donor preparation techniques, recipient bed preparation techniques, donor insertion techniques, and the surgical outcomes observed so far in the literature.
Methods of Literature Search
We performed a literature search on the Pubmed database on June 1, 2021 using the following keywords: DMEK, techniques, outcomes, complications using “AND” and “OR”. A total of 426 articles were available on search; however, we limited our search to full-text articles written in English. Case reports, comments, letters to the editor, articles written in other languages, and duplicate articles were excluded from the study. A total of 162 articles were finally selected to be included in the study based on the relevance and availability of articles. Relevance was assessed after reading the abstracts of the articles. To avoid selection bias in selecting articles three independent selectors were appointed.
Preoperative Considerations for DMEK
Donor related
Donor age is an important consideration when planning for DMEK. Younger donors produce tighter scrolls and can cause difficult unfolding of graft intraoperatively and subsequent endothelial cell loss.[4] The older donors have a less tight scroll and often have a lesser tendency to scroll. These physiological characteristics can influence the unfolding of the DM roll during surgery. However, the functional outcomes are comparable between young and old donors.[5] The minimum endothelial cell density criteria can vary from various eye banks. As per the standard operating procedures of eye banks in India, a donor cornea with a minimum endothelial cell density of over 2400 cells/mm2 is considered suitable for DMEK.
The diabetic status of the donor is believed to be an important parameter to look for while considering donor preparation. The literature suggests an adhesive interface between the posterior corneal stroma and DM in diabetics.[6,7] This results in an increased incidence of graft tearing during graft preparation and subsequent graft preparation failure.[8] However, donor diabetes status did not result in increased rebubbling rate and postoperative increased endothelial cell loss at 6 months.[9]
Recipient related
The cornea should be relatively clear to allow sufficient visualization of graft in the anterior chamber and its manipulation.[10,11,12] So, DMEK is not ideal for situations of corneal decompensation with severe corneal haze and scarring that precludes the anterior chamber view.
The anterior segment biometry is another parameter that needs to be evaluated before surgery. It depends on the axial length, corneal diameter, and lens status of the patient. Biometry of the eye using diagnostic tools such as anterior segment optical coherence tomography (OCT) and optical biometry devices helps in deciding the appropriate size and shape of graft depending on the availability of space. In general, the graft size is 2-3 mm smaller than the horizontal corneal diameter. Corneas with increased keratometry readings may need a larger size of the graft because of the increased posterior corneal surface area.
Preoperative assessment for DMEK in PKP graft includes the use of modalities like anterior segment optical coherence tomography to assess the graft–host junction, undesired posterior morphological changes, or peripheral anterior synechiae.[13]
Surgical Steps of DMEK
The surgery involves DM roll preparation, graft insertion, unfolding the graft, and its attachment with air bubble tamponade. Fig. 1 illustrates few surgical steps of the surgery.
Figure 1.
Showing DMEK surgical steps. (a) Peripheral lifting of DM–endothelial complex using sinsky hook. (b) DM–endothelial complex peeling. (c) DM scroll. (d) Loading of DM scroll. (e) Injection of DM scroll into the anterior chamber. (f) DM scroll in AC. (g) Unfolded DM scroll in the anterior chamber. (h) DM scroll fastened to the posterior corneal surface using an air bubble. (i) Post-DMEK at 1-week follow-up
DMEK donor tissue preparation
There are various techniques described for endothelial graft preparation with no consensus on a uniform standard method. Broadly the techniques for donor tissue preparation can be categorized into manual peeling or techniques aiming at achieving detachment between DM and posterior stroma by using either air or fluid utilizing the similar concepts of anterior lamellar keratoplasty.[14] The donor tissue preparation techniques along with advantages and disadvantages have been summarized in Table 1.[15,16,17,18,19,20,21,22,23,24,25,26,27,28,29,30,31,32,33,34]
Table 1.
Donor preparation techniques and advantages and disadvantages of each procedure
| Techniques | Basic principle | Modifications | Advantages | Disadvantages |
|---|---|---|---|---|
| A. Manual peeling | ||||
| 1. Melles et al. | Superficial trephination BSS immersed donor tissue Single-handed DM peeling |
|||
| 2. Zhu et al. | Tissue mounted on the artificial anterior chamber with the endothelial side up No underwater system 4 incisions on DM DM peeling in a rectangular fashion |
Rectangular cuts instead of trephine cuts gave the advantage of a long flat edge to grasp and peel the DM smoothly Simple Fast No new instrument Endothelial loss <3% |
Endothelial damage at the site of grasping Donor tissue with >2 mm scleral rim to mount on artificial anterior chamber 8/48 had tearing The size of DM preparation is limited by the length of platform forceps |
|
| 3. Lie et al. | 180-degree loosening of DM from the scleral spur | Acceptable ECL | Linear streaks reflecting disrupted endothelial cell junctions which restored Focal ECL during forceps manipulation |
|
| 4. Groeneveld -Van- Beek | 360-degree DM and adjacent TM loosening Trephination on -6 D contact lens |
No-touch technique Stripping DM with a peripheral rim of TM facilitate thin graft handling No damage to the stromal bed and hence useful for DALK |
||
| 5. Giebel et al. (SCUBA technique) | DM stripping in viewing chamber Tissue submerged in storage solution |
Better tissue visualization Easier to rescue in case of tears |
12/72 DM tear | |
| 6. Tenkman LR | Y Hook for scoring to produce a smooth break Blunt micro finger for 360-degree edge lift: Glide technique 4 quadrant “Corridor method” of DM peeling using Tubingen forceps |
Edge lifting was guided by the concept of progressing from areas of minimum tension (peaks) to areas of maximum tension (craters) - Corridor method helped to minimize tension during peeling |
HST 13% | |
| 7. Kruse et al. | 2 forceps technique to lift DM similar to lifting a tablecloth Razor blade to scratch peripheral DM and edge lift with round blade Orientation mark with 1 mm trephine |
Scratching the DM outside prevented the EDM from tearing inside 2 Forcep technique decreased the surface tension Reproducible Minimal tearing |
Increased preparation time (decreased from 1.5 h to with experience) | |
| 8. Yoeruek et al. | 2 novel untoothed forceps for DM peeling - Curvilinear 8 mm dissection forceps and mmicro tears forceps | Faster Lower endothelial cell loss 8 mm dissection forceps allowed immediate preparation of membrane with minimal grasping rate Microtear forceps increased tissue salvage |
Novel instruments - Study used old donor tissue |
|
| 9. Sikder et al. | 400-µ head microkeratome to remove the majority of stroma Manual dissection of residual stroma |
- Thin rim of posterior residual stroma permits easy donor button trephination and tissue | Possible perforation during manual removal of stroma manipulation - Risk of tearing through DM is minimal - Relatively easy assessment of endothelial integrity before trephination |
|
| 10. Tausif et al. | - Microtears used as a hinge for DM peeling | - Cost-effective - No specialized instrument |
Overall 76% success rate (increased from 72% in first 25 cases to 80% in next 25 cases, prepared by eye bank technicians) DM tear (10%) Severe cell loss (14%) in cases with difficulty in remounting the tissue and incomplete DM edge stain |
|
| 11. Maharana et al. (SHARP technique) | Sinskey hook for freeing DM edge Bimanual DM peeling |
Simple Easy Cost effective - No specialized instruments |
Success rate 86.6% (13/15) Complete success in 66.6% and partial success in 20% |
|
| 12. Tzamalis et al. (Yogurt technique) | Novel DMEK punch (100 µ guarded blade and missing 1 Clock hour) to create an uncut hinge Single-peel technique |
DM is stripped easily from its a natural end point, that is, Schwalbe’s line Shorter preparation time as circumferential DM detachment is not needed Reproducible Low failure rate independent of surgeon’s experience level |
Specially designed punch | |
| B. Pneumatic dissection | ||||
| 13. Ignacio et al. | Air injection to achieve detachment between DM and posterior stroma | - 9-mm trephination and air injection in the artificial anterior chamber | ||
| 14. Busin et al. | Anterior stroma removed with 300-µ head microkeratome before air injection Residual donor tissue placed endothelial side up and 30 G needle used to inject air |
The dissected sclerocorneal rim can be stored There is no rolling of tissue and hence peripheral ECL is prevented Easy transfer of tissue from preparation site to insertion site Touch-free technique Less ECL No added skill is required to master the technique |
Rare chance of failure to obtain big bubble (1/20) | |
| 15. Venzano et al. | Applied Anwar air bubble technique Trypan blue stained endothelium to facilitate proper positioning of the air injection needle Hypotony before air injection |
Depth of needle and adequate hypotony helped in successful DM separation | A pilot study with small sample size | |
| 16. Zarei Ghanavati et al. (Reverse big bubble technique) | Tissue mounted endothelial side up with air injection in the posterior stroma Older tissue with high endothelial cell count preferred |
Better visualization with the endothelial side up Faster, easier, and without endothelial touch during detachment as compared to manual dissection Short learning curve |
Younger donor tissue resulted in 1 DM rupture and 1 incomplete detachment out of 10 cases | |
| 17. Studeny et al. (DMEK-S) | Big bubble achieved with donor tissue mounted endothelial side up Central 6 mm DM endothelial complex with surrounding 1 mm wide 100-µ thick stromal rim |
Easy tissue handling due to presence of stromal rim No special instrument |
-Larger width of tunnel incision (4.75 vs 3.50)( but still sutureless) - Rate of loss of donor cornea due to bubble rupture (decreased from 10 to 5% with experience ) |
|
| 18. Agarwal et al. (PDEK) | PDL, DM, and endothelium transplanted Donor tissue mounted endothelial side up 30 G needle used to obtain Type I Bubble Trypan blue used to stain the tissue |
Easier tissue handling due to PDL Less haze due to less keratocytes Allowed use of younger donor tissue<50 years |
Mean graft diameter is lesser than usual DMEK graft and hence fewer endothelial cells are transplanted (compensated with less ECL during preparation and younger donor tissue use) Chances of creation of type 2 bubble instead of type 1 bubble |
|
| C. Hydrodissection | ||||
| 19. Muraine et al. | Fluid injection to achieve detachment between DM and posterior stroma | DM sectioned 330 degree Endothelium detached from nontrephined zone to create a liftable flap 27 G cannula used to inject fluid |
Simple Less ECL The endothelium is rolled in |
4% Graft loss (seen in younger donors) |
| 20. Salavalaio et al. (Sub Hys) | Donor tissue immersed in organ culture media 25 G needle to inject fluid Anterior stroma trephined after mounting donor tissue on custom-made artificial chamber with the epithelial side up |
Standardized, no-touch, ready to use tissue Reduced preparation time The graft can be preserved in deturgescent medium for up to 7 days |
Bubble burst due to liquid overfilling in 5 out of 30 cases Average ECL postpreservation 27.69% |
|
| 21. Szurman et al. (Liquid bubble technique) | Donor tissue placed endothelial side up Trypan blue injected to obtain DM detachment after negating 2 mm area of strong DM adhesion The first technique to describe selective staining of the stromal side of DM |
Rapid and easy Highly reproducible No special equipment needed Minimal tissue manipulation Selective staining of the stromal side of DM, thus, avoiding direct contact with endothelial cells and producing a homogenous stain Rescue technique in case of tearing or strong adhesions |
1/86: central tear |
Recipient bed preparation
For a recipient bed preparation, a correct estimate of the anterior chamber dimension is needed. Depending on the available free posterior corneal surface, a rough estimate of the recipient bed size is made. The corneal tunnel configuration and extent are subsequently decided based on the recipient bed size.
Kruse et al.,[21] in their study, used a 9-mm trephine mark on the anterior corneal surface to guide the recipient bed size. Tunnel at 12’O clock with paracentesis at 3, 11, and 1’O clock was suggested in this study. The descemetorhexis was done through the paracentesis under air with an inverted hook. Güell et al.[35] also suggested descemetorhexis under air with reversed Sinskey hook via superior 2.4 mm corneal tunnel. The paracentesis was made at 3 and 9 O’ clock positions in this study. Owing to the better visualization under air descemetorhexis has been advocated to be done under air in most of the available literature.[36,37,38] In a study by Takahiko Hayashi et al.,[39] the author proposed a standard technique for descemetorhexis; however, the author used Hayashi DMEK stripping forceps to remove the DM from the anterior chamber. The literature search also revealed the use of viscoelastic for descemetorhexis.[40,41] The author also advised roughening of peripheral 2 mm of the bare stroma with the scraper to facilitate better graft adherence.[41] In cases with endoglide-assisted insertion of graft, a temporal scleral tunnel making is preferred with a nasal paracentesis for endoglide placement forceps to pull the graft into the anterior chamber.[37]
Donor Insertion Techniques and Devices
There are various considerations while inserting the donor graft inside the anterior chamber. Among the various technical nuances during insertion of DMEK graft, maintenance of anterior chamber depth, the donor graft orientation, and method of delivery of graft are important. The literature suggests different methods to facilitate smoother graft insertion with minimal damage to endothelial cells.
Graft delivery techniques and devices
Kruse et al.[21] used an injector cartridge used for intraocular lens implantation for graft loading and insertion into the anterior chamber. For graft loading, the author used a pre- fluid-filled cartridge such that the graft roll floats into the cartridge. The injector is inserted into the anterior chamber and the graft injected.
Güell et al.[35] also used a 1.8-mm prefilled cartridge for graft loading and injection; however, they suggested the use of a small air bubble at the rear end of the DM scroll. Price et al.[42] also used an intraocular lenses (IOL) cartridge for graft insertion in their study; however, for graft loading, the Tan forceps were used. In another study using IOL cartridge, flushing was compared with the pushing technique of DMEK graft insertion revealing prolonged insertion to attachment time when the graft is flushed. However, it did not affect the outcome.[43]
Dapena et al. in their study used a no-touch technique with a customized glass pipette or a Pasteur glass pipette for loading and delivery of graft into the anterior chamber. The author postulated that the glass surface unlike plastic cartridges is smooth and less traumatic and can be made without sharp edges.[36] However, the small entry port causes friction trauma and, thus, potentially more damaging to the endothelial cells. Melle’s glass injector offered a less traumatic graft loading because of the large lumen for entry; however, the assembly and disassembly of the glass injector are cumbersome. In an attempt to overcome the friction-related trauma during graft loading and cumbersome maneuvers in loading and injecting the graft, FA Montiel suggested the use of an asymmetric double port injector.[44] All these injectors seemed expensive and supposedly did not have a closed system, causing inadequate fluid control and an increased risk of contact of graft tissue with the wall of the injector. Kim et al.[45] proposed the use of a relatively inexpensive and effective injector with a closed system to facilitate adequate fluid flow around the graft tissue. The author used the cut end of intravenous tubing mounted over prefilled syringe with the Alcon IOL B cartridge at the proximal end. The outcomes were comparable with larger series where a glass injector has been used. In a similar study by Mehrnaz Ighani et al.,[41] the author used the Bonfadini–Todd injector (comprised of Alcon B cartridge, plastic tubing, and syringe) for graft insertion. The technique described is not only inexpensive but also gives equally good surgical outcomes.
In a multicenteric study, the author noted a higher postoperative graft detachment rate in cases where plastic graft inserters were used compared to glass inserters. A high detachment rate has been attributed to more endothelial cell damage, possibly due to graft touch inside the inserter due to electrostatic charges.[36]
In another study by Marcus Ang et al.,[37] the author advised the use of endoglide and the D-Mat-assisted DMEK graft delivery system. The development of this device potentially decreases the endothelial loss occurring during graft insertion. A similar study by Tan et al.,[46] suggests lesser endothelial damage with endoglide-assisted DMEK with promising clinical outcomes. Hybrid DMEK by the pull-through technique is a modification of the above-described technique with the use of stroma in place of D-Mat.[47] The author emphasizes that the endothelium-in configuration during insertion decreases cell loss; however, another study comparing endothelium-in with endothelium-out insertion of DMEK graft revealed similar outcomes with either of the techniques.[42] In another ex vivo study by Chong et al.,[48] greater endothelial cell viability was noted with the endothelium-in technique compared to the endothelium-out technique. The timing of preloading of the graft into the device is having a significant bearing on the scrolling tendency of the DMEK graft. If preloaded 48 h before the surgery, the graft scrolling tendency decreases for 2 min and gives sufficient tme to the surgeon to fix the graft before it recurls.[49]
A novel technique of donor insertion described by Fogla et al.[40] uses a glass cartridge attached to the prefilled syringe. The cartridge is inserted into the AC and rotated to orient the graft in the desired orientation. The AC maintainer is switched off and disconnected from the intravenous tubing followed by graft injection. The absence of fluid counterpressure facilitates a smooth delivery of graft in the correct orientation.
In another technique for the graft insertion, the infusion cannula is directed to the internal lumen of the cartridge from the opposite paracentesis. This draws the graft into the anterior chamber with a no-touch technique.[50]
Graft unfolding and attachment techniques
The various techniques can be used either as standalone or in various combinations depending upon the clinical situation and the expertise of the surgeon. Liarakos et al.[51] retrospectively evaluated various techniques for the unfolding of DMEK graft in their 100 consecutive cases and found no correlation between the technique chosen to unfold the graft and postoperative outcomes in terms of visual acuity, endothelial cell counts, and complication rates. The technique employed to unroll a graft inside the anterior chamber depends on factors such as the orientation of the double Descemet roll-formed, the tightness of the folds, and whether the two halves are symmetrically folded or not.
A) Successful formation of a symmetric double Descemet roll
Standard No-Touch technique[52]
The formation of a double Descemet roll is the most essential part of this technique. The formation of the Descemet roll is ensured by irrigating the Descemet roll using the balanced salt solution so that the graft opens and folds back on itself forming two adjacent rolls. Following graft injection into the anterior chamber, the position of the folds is checked by the Moutsouris sign. In case the graft is oriented correctly with the curls of the double roll facing upwards, the tip of the cannula positioned inside a peripheral curl appears blue due to the overlying blue-colored donor tissue suggestive of a positive Moutsouris sign. However, if the graft is positioned with edges facing downwards, the tip does not change its color since it is not able to find the curls. This is referred to as the negative Moutsouris sign.[51,52]
The first separation of the graft is achieved by gently taping the outer cornea followed by injection of an air bubble between the rolls and then subsequently enlarging it. Air bubble aims to secure the graft in its upright position and allow for its centration. The bubble is enlarged to fixate the graft onto the iris, while the peripheral part of the graft is being opened. Once the graft is completely opened up, the air bubble lies in the interface between the graft and the cornea is aspirated and injected beneath the graft to secure it onto the host stroma.
B) Symmetric double Descemet roll is not formed
a. Dirisamer technique
The technique is employed in case an asymmetric double roll is formed, consisting of a small flange adjacent to the larger body of the Descemet roll. It utilizes 2 cannulas, one to stabilize the relatively less folded part of the graft by gently pressing over the corneal surface and the second to unfold the tightly rolled part of the Descemet roll.[51]
b) Dapena maneuver
This technique involves positioning a small air bubble over a partially unfolded graft. The graft is unfolded by manipulating the air bubble from the outer corneal surface using a blunt cannula. The presence of an air bubble acts as an intraocular tool and helps in unrolling the flanges of the graft.[51]
c) Single-sliding cannula maneuver
Loose Descemet rolls wherein the graft has a tendency to unfold on its own are better suited for this technique. This method involves the application of repetitive sliding movements over the anterior corneal surface, keeping the cannula parallel to the Descemet roll in a centrifugal manner.[51]
C) Double Descemet roll placed in an upside-down manner: “Flushing”
In case the double roll is oriented in an inverted manner after injecting inside the anterior chamber, as confirmed by a negative Moutsouris sign, the graft is repositioned by gentle flushing using the balanced salt solution, injected from one of the side ports.[51]
D) Persistent small folds in an otherwise completely opened Descemet’s roll: “Bubble Bumping”
Once the Descemet roll is completely opened up, small, localized undulations or inward folds may interfere with the complete apposition of the graft with the posterior stroma. Gentle taps applied over the anterior corneal surface localized to the area of inwards folds help to completely open up the graft.[51]
Techniques to know correct orientation of DMEK graft within the anterior chamber
Moutsouris sign/the “Blue Cannula” tip sign [Dapena I et al.][51]
Stamped DMEK grafts [Veldman et al.][54]
Placement of a single peripheral triangular mark [Rickmann et al.][53]
Use of paired asymmetric marks [Matsuzawa et al.][55]
Peripheral graft staining/”Ghost DMEK” technique [Livny et al.][56]
Kobayashi or the K sign (endo-illuminator assisted) [Kobayashi et al.][57]
Use of intraoperative ultrasound biomicroscopy [Nahum Y et al.][58]
Microscope integrated OCT-aided visualization [Steven P et al.].[59,60,61]
Complications and Management
The complications of DMEK have been enumerated along with various predisposing factors and management in Table 2.
Table 2.
Summary of complications, predisposing factors, and their management
| Complications | Risk factors | Management |
|---|---|---|
| 1. Graft detachment | Host Factors: Incomplete DM removal Smaller descemetorhexis Improper graft orientation Posterior vitreous pressure Postoperative ocular hypotony Donor Factors (conflicting evidence) Donor tissue age Storage medium In some studies, younger donors and tighter rolls and tissue stored in cold storage had a higher detachment rate as compared to organ culture storage Surgeon inexperience |
Staining for proper visualization of DM and careful intraoperative inspection under air to ensure complete DM stripping Avoid the use of plastic or viscoelastic material Larger descemetorhexis Femtosecond-enabled descemetorhexis produces a smooth interface Marking the graft, checking the orientation with Moutsouris sign or intraoperative OCT Intraoperative soft eye by ocular massage or applying Honan balloon for 10 min, avoiding tight eyelid speculum and maintaining antitrendelenburg position Consider prolonged postoperative air tamponade for at least 1 h or use gas which persists longer in the eye, especially in aphakic or vitrectomized eyes or eyes with glaucoma shunts Rebubbling with 100% air or 12–14% C3F8 or 20% SF6 for detachments which are complete or central and for peripheral detachments involving >1/3rd graft surface area following an AS-OCT based algorithm performed at 1 h, 1 week, and 1 month Repeat transplant Refinement in technique and surgeon experience |
| 2. Raised IOP | Exacerbation of preexisting glaucoma Preoperative raised IOP Angle supported phakic IOL De-novo glaucoma Air bubble-induced mechanical angle closure Steroid response PAS |
Close IOP monitoring in patients with risk factors Reducing residual post-op air bubble Inferior PI Air release and dilatation Switch to low-potency steroids Avoid DMEK graft decentration to prevent PAS formation |
| 3. Graft rejection | Ethnicity: Asians have a stronger immune response than Caucasians Noncompliance to topical steroids |
Routine follow-up to detect subtle findings of asymptomatic endothelial rejection Resumption of topical steroids |
| 4. Graft failure | Primary : b Intraoperative graft manipulation Subclinical pre-op endothelial dysfunction Inverted graft transplantation Storage of precut tissue in deswelling medium with dextran and insufficient rinsing of media remnants before insertion Secondary: Endothelial failure – patients with glaucoma/postsecond rebubbling Graft rejection Graft survival FECD >BK |
Careful screening in eye banks to rule out subtle endothelial changes as in pseudoexfoliation syndrome Less intraoperative manipulation and correct graft orientation Repeat DMEK |
| 5. Pupillary abnormality | An acute increase in IOP, especially in the first 24 h, leads to iris ischemia with sphincter muscle dysfunction Air tamponade >70% Intraoperative pupillary dilatation along with longer retention of SF6 Shallow AC Triple procedures have increased risk of synechiae Learning curve |
Use of air over SF6 Early synechiolysis Surgeon experience |
| 6. Cystoid macular edema | DMEK combined with cataract surgery Short AL Longer duration of surgery Iris manipulation Predisposing risk factors like contralateral CME, PG analog use, ERM, DR, macular degeneration, previous retinal surgery, RVO, VMT |
Intensive topical corticosteroids in the first week of DMEK with cataract surgery Minimal iris manipulation |
| 7. Cataract | Age Iatrogenic injury to the anterior lens capsule Increased duration of air and lens contact |
Intraoperative pupil constriction Decrease the air bubble to 30% at the end of the surgery Cataract surgery for clinically significant cataract |
| 8. IOL calcification | Inflammatory reaction with disrupted blood–aqueous barrier Metabolic changes in aqueous humor Dehydrated hydrophilic acrylate in contact with air leads to deposition of hydroxyapatite on the IOL surface Calcification of hydrophobic IOL and hydrophilic IOL with hydrophobic coating has also been reported |
Symptomatic IOL opacification needs IOL explantation |
Outcomes of DMEK in Various Clinical Scenarios
Since the first published report of preliminary clinical results of DMEK by Melles G et al. in 2008,[65] corneal surgeons across the world were motivated to adopt this new technique of selective endothelial layer transplantation. In a nonrandomized study involving 10 patients with either Fuchs endothelial corneal dystrophy (FECD) or pseudophakic bullous keratopathy (PBK), DMEK was performed using DM rolls prepared from organ-cultured donor corneoscleral rims. At 1 month postoperatively, 6 out of 10 eyes achieved a best-corrected visual acuity (BCVA) of 20/40 or better of which 3 eyes reached 20/20. The observation of such a quick and nearly complete visual recovery as compared to the previously described posterior lamellar transplantation techniques such as deep lamellar endothelial keratoplasty (DLEK) and DMEK made the authors conclude that the surgical procedure might have a potential to surpass other well-accepted methods of endothelial transplantation. This observation of early visual recovery following DMEK was further strengthened in a subsequent larger nonrandomized study by the same authors involving 35 patients with FECD and PBK.[136] In most cases, functional visual improvement was obtained within 1–3 months. The long-term sustainability and predictability of DMEK were further proved in a subsequent study, wherein a subset of patients was followed up to 24-month postoperative period. A 25% rate of endothelial cell loss was noted in the early postoperative phase (1–2 years), which was quite similar to that reported with other techniques of EK.[137] In a prospective, multicentric trial by Price et al.,[138] the results of DMEK were evaluated in 60 eyes with FECD, PBK, and failed graft. The median best spectacle-corrected visual acuity (BSCVA) at 1 month was 20/30 with 94% eyes achieving 20/40 or better at 3 months. The endothelial cell loss was 30 ± 20% at 3 months follow-up and 32 ± 20% at 6 months, consistent with the previous reports of DMEK. The main complication observed was partial graft detachment, occurring in 63% of eyes predominantly clustered in the first 2 weeks.
Further studies evaluating long-term outcomes of DMEK over 3 and 5 years[139] reported a cell loss of 42 and 55%, respectively. A biphasic pattern of endothelial cell loss was observed with a sharp decline of 20–29% in the first 6 months followed by a slow decline of approximately 10% per year. The pattern of endothelial cell loss observed was found to be similar to that seen after other forms of endothelial keratoplasties.
The favorable outcomes of DMEK in initial studies in terms of “quick” and “nearly complete” visual recovery substantiated the concept that thinner grafts help to achieve better visual outcomes.[140] In today’s date, the literature is replete with both comparative and noncomparative studies, evaluating the outcomes of DMEK in comparison with other forms of endothelial transplantation such as DSAEK and ultrathin DSAEK and as a standalone procedure in various clinical scenarios. Over a e while newer advancements have been incorporated such as the use of intraoperative OCT[61,59] to help in intraoperative and postoperative decision making and the use of femtosecond laser for assisting descemetorhexis.[141]
a) Changes in corneal biomechanical and optical properties after DMEK
DMEK allows near-normal visual, anatomical as well as ultrastructural rehabilitation without altering the biomechanical properties of the cornea. Shilova NF et al.[142] evaluated compared the biomechanical properties of DMEK-operated PBK eyes with normal fellow eyes, using an ocular response analyzer. The operated and normal fellow eyes were comparable in terms of mean values of corneal hysteresis and the corneal resistance factor.
In a comparative study by Rudolph M et al.,[143] corneal higher-order aberrations were evaluated in eyes undergoing DMEK, DSAEK, penetrating keratoplasty (PK), and in unoperated control eyes. Compared to PK and DSAEK, DMEK eyes showed significantly lower values of mean higher-order aberrations for the central 4-mm zone of the posterior corneal surface. This was accompanied by a significantly better BSCVA in DMEK eyes compared to both DSAEK and PK. These findings were attributed to the minimal alteration of the posterior corneal surface and attainment of a near-normal corneal anatomy, in eyes undergoing DMEK.
b) DMEK in eyes with FECD [Fig. 2]
Figure 2.
Representative slit-lamp photographs (a and b), OCT images (c and d), specular microscopy (e and f) of the right and left eye of 8 year follow-up after DMEK triple. The patient had Fuchs endothelial dystrophy. At the 8 year follow-up, the endothelial imaging shows an endothelial cell loss (ECL) of 53 and 50% from baseline donor. Endothelial cell density (EDC) in the right and left eye, respectively
The first series of DMEK performed in patients with FECD was reported by Ham L et al.[144] in 2009. This nonrandomized study reported the outcomes of DMEK performed in 50 consecutive cases of FECD. Of the 50 eyes, 10 experienced graft failure, predominantly due to graft detachment; either partial or complete, requiring secondary DSEK. In the remaining 40 eyes, 95% attained a BCVA of 20/40 with 75% of them reaching up to 20/25, at 6 month follow-up. The overall visual recovery was found to be comparable to PK and other techniques of EK such as DLEK and DSEK/DSAEK with the added advantage of nearly complete visual recovery in the majority of patients within 1–3 months. The endothelial cell loss at 6 months was approximately 30%, with cell counts averaging around 1876 ± 522 cells/mm2, comparable to other forms of keratoplasties.
Zwingelberg SB et al.[145] reported the long-term outcomes of DMEK performed in a large study comprising of 402 eyes, including 371 eyes with FECD and 31 eyes with PBK. Three years following DMEK, a significant decline was noted in the central corneal thickness with no change in the peripheral corneal thickness. The BSCVA was comparable among the two groups at 3 years follow-up.
Cabrerizo J et al.[146] evaluated following DMEK in eyes with bilateral FECD, in terms of color vision and contrast sensitivity, and overall patient satisfaction. Results were compared between the untreated FECD-affected eye and the DMEK-treated FECD eye. Following DMEK, a significant improvement in contrast sensitivity was noticed besides improvement in the BSCVA. Comparing phakic and pseudophakic eyes, phakic eyes performed better in terms of improvement in contrast sensitivity. Color vision was, however, comparable among the treated and the untreated groups.
c) Outcomes of DMEK in phakic eyes
Removing or retaining the crystalline lens has been a matter of debate among corneal surgeons while performing EK. The observation is that most patients which are planned for EK have some degree of cataract which may be aggravated by intraocular surgery and use of postoperative corticosteroids. Another clinical observation has been that phakic eyes have been seen to perform better compared to pseudophakic eyes, following EK. Loss of accommodation, posterior capsule opacification, and changes in the optical properties of the lens system are factors that contribute to the degradation of visual quality in pseudophakic eyes. In a study by Parker J et al.,[124] the outcomes of DMEK performed in phakic eyes with FECD were compared with age-matched pseudophakic patients. Visual acuity equal to or better than 20/13 was observed only in phakic eyes, suggesting better optical quality with the crystalline lens in situ. Both groups were similar in terms of complication rates.
d) Outcomes of DMEK combined with phacoemulsification and IOL implantation (DMEK triple procedure)
Studies reporting the outcomes of DMEK combined with cataract surgery in eyes with FECD and preexisting cataracts have shown predictable and stable refractive results without any added risks of postoperative complications, compared to DMEK alone.[89,147,148] In eyes with significant cataracts, performing cataract surgery along with replacing the diseased endothelium offers faster visual rehabilitation and cut shortens the costs and risks associated with a second intraocular procedure. Chaurasia et al.[89] compared the clinical outcomes of DMEK single versus triple procedure in a retrospective study involving 492 eyes with either FECD, secondary corneal edema, or a prior failed EK. The authors observed similar rates of air reinjection and median endothelial cell loss (26%) in both groups at 6 months follow-up. Ensuring complete removal of viscoelastic substance before initiating descemetorrhexis and a well-placed IOL were considered important factors determining the overall success of the combined procedure.
e) DMEK combined with IOL implantation in aphakic eyes
Apart from the routine technique of phacoemulsification and in-the-bag IOL implantation, DMEK has also been combined with other methods of IOL implantation such as iris claw and scleral fixated IOLs in eyes with aphakic bullous keratopathy.[149,150,151] Seven consecutive eyes with bullous keratopathy, without adequate capsular support, underwent DMEK and posterior iris-claw implantation with favorable visual results and a mean endothelial cell loss of 24.8% at 7 months follow-up.[151] Four eyes experienced graft dislocation which could be successfully reversed with air reinjection. Koçluk Y et al.[150] combined the implantation of sutureless intrascleral fixation of IOL as well as sutured transscleral fixation with DMEK in 21 eyes with aphakic bullous keratopathy. Nine eyes required rebubbling for settling detached grafts in the early postoperative periods. The overall graft adhesion rate was 85.7%, at last, follow-up visit.
f) DMEK in buphthalmic eyes with glaucoma drainage devices
Transplantation of normal or large diameter DMEK grafts has been seen to benefit buphthalmic eyes by transplanting a large number of endothelial cells with reduced risks of rejection in comparison to PK and DSAEK. The altered anatomy of the anterior segment poses several challenges in the form of difficult descemetorhexis due to the presence of Haab striae with string attached to the underlying stroma, presence of glaucoma drainage devices hindering in the unfolding of graft, and difficulty in achieving an adequate air fill of the anterior chamber interfering in proper graft adherence. The intraocular pressure should be adequately controlled before planning surgery in such eyes. Quilendrino R et al.[152] observed graft detachment in two out of four adult eyes with buphthalmos, following DMEK. Mean endothelial cell loss ranged between 37 and 42%.
g) DMEK in eyes with prior failed graft
EK in eyes with prior failed PK allows visual rehabilitation with much less incidence of complications compared to a repeat full-thickness graft. Among the two popular techniques of EK, DMEK grafts are supposed to better fit the undersurface of a full-thickness graft. This is due to the flexibility of the graft which allows it to stretch across the irregular posterior surface of the graft, compared to a stiffer DSAEK graft. Clinical outcomes are limited by the optical quality of the prior graft and the presence of other ocular comorbidities[13] and may not be comparable to that of a primary DMEK. These eyes are more prone to postoperative graft detachments and, therefore, should be closely monitored. In a study of 28 eyes with failed PK which underwent DMEK,[153] 43% had graft failure and required repeat grafting. Factors such as better visual acuity at presentation, use of femtosecond laser for descemetorhexis, and a lower rebubbling rate were associated with a lower risk of graft failure.
h) Outcomes of repeat DMEK
Deciding when to intervene secondarily, while observing eyes with detached grafts, is an important factor determining the outcomes of the second surgical procedure. Price et al.[154] observed that in patients who received prompt intervention following a failed DMEK, the visual outcomes of secondary DMEK in such eyes were comparable with the primary DMEK. A paired fellow eye analysis was done in 29 eyes, wherein the outcomes of secondary DMEK were compared with the outcomes of primary DMEK performed in the fellow eye. The primary and secondarily grafted eyes were comparable in terms of visual acuity, central corneal thickness, and endothelial cell loss at 1-year follow-up. The authors advocated early intervention to minimize the duration of poor vision, symptomatic bullae, and restricted activities.
i) Femtosecond laser-assisted DMEK (F-DMEK)
The use of femtosecond laser for the creation of descemetorhexis in eyes undergoing DMEK is a newer addition to the armamentarium of laser refractive surgery. The creation of a precise and complete descemetorhexis in eyes undergoing DMEK is deemed important for the successful attachment of graft as any tags or residues remaining in the graft–host interface preclude the graft from adhering at that site. The use of femtosecond laser allows the creation of a precise descemetorhexis, avoiding inadvertent excess removal of host DM and limiting the size of the bare area. In a comparative study of 16 eyes with FECD, eyes that underwent F-DMEK had significantly less rate of postoperative graft detachment and consequently less number of rebubblings required.[155] Endothelial cell loss was significantly lower in the F-DMEK group till 2 years follow-up.
j) Outcomes of hemi-DMEK
Hemi-DMEK involves transplantation of “half-the-circle” of a full-sized untrephined DM. The concept of hemi-DMEK was devised as a potential method for increasing the pool of endothelial graft tissue.[156] Instead of discarding the peripheral rim of endothelial cells, the full-size DM is cut into two semicircular halves and used for transplantation in two eyes. The preliminary outcomes of hemi-DMEK performed in 10 eyes with FECD suggested[157] visual outcomes comparable with that of standard circular DMEK. The 6-month decline in ECD was, however, higher than the standard DMEK procedure. Of the 10 eyes, 4 had visually significant detachments, while another 4 had visually insignificant peripheral detachments. The authors suggested disparity in graft curvature and difference in the elastic properties of the central and peripheral cornea to account for difficult graft adhesion in these eyes. Long-term studies are warranted to fully understand the amount and pattern of endothelial cell loss and graft rejection rates, following hemi-DMEK.
The outcomes of DMEK in various clinical scenarios are summarized in Table 3.
Table 3.
Summary of comparative as well as noncomparative studies reporting the outcomes of DMEK in various clinical scenarios
| Author/Year | n | Study design | Indication | Intervention | Outcome |
|---|---|---|---|---|---|
| Zwingelberg SB et al./2021 | 402 | R | FECD (n=371) PBK (n=31) | DMEK | At 3-year follow-up, BSCVA improvement in FECD and PBK eyes was comparable |
| Cabrerizo J et al./2014 | 29 | R | Bilateral FECD | Unilateral DMEK | DMEK eyes had significantly better visual acuity and contrast sensitivity compared to the untreated FECD eyes. The color vision was, however, comparable among the two groups. Subjective optical quality was better in DMEK-operated eyes compared to fellow untreated eyes both in phakic eyes as well as in pseudophakic eyes |
| Parker J et al./2012[124] | 99 | P Comparative | FECD | DMEK | Phakic and pseudophakic eye groups were comparable in terms of final visual outcome, visual rehabilitation rate, ECD, and complication rate at 6 months follow-up |
| Shilova NF et al./2019[142] | 40 | R Comparative | PBK | DMEK | The mean CH and mean CRF values did not show any statistically significant difference between the DMEK and the normal fellow eyes. Mean CCT was smaller in the operated eyes compared to the fellow eyes. However, the CCT value did not show any correlation with either the CH or the CRF values |
| Dunker SL et al./2020 | 54 | RCT | FECD | DMEK (n=29) vs UT-DSAEK (n=25) | Comparable mean BSCVA, endothelial cell density, and hyperopic shift noted at 12 months follow-up. DMEK group had a significantly higher percentage of eyes with 20/25 Snellen acuity |
| Mencucci R et al./2020 | 18 | R | FECD | DMEK vs UT-DSAEK (fellow eye comparison) | Comparable BSCVA noted at 12 months follow-up. Total and posterior corneal higher-order aberrations, posterior astigmatism, and total coma was significantly lower in eyes following DMEK. Visual acuity in both groups was found to significantly correlate mainly with anterior corneal aberrations. DMEK eyes performed better in terms of contrast sensitivity, posterior corneal aberrations, and overall patient satisfaction |
| Romano V et al./2020 | 56 | R | FECD and PBK | Preloaded UT-DSAEK (n=31) vs preloaded DMEK (n=25) | At 12 months, logMAR BSCVAwas significantly better in eyes undergoing Preloaded DMEK, compared with pl-UTDSAEK. (0.37±0.37 LogMAR, P<0.01). The percentage of people that achieved ≥20/30 was significantly higher in the preloaded DMEK group. The rate of rebubbling, however, was significantly higher for the same group |
| Duggan MJ et al./2019 | 50 | RCT | FECD and PBK | UT-DSAEK (n=25) vs DMEK (25) | At 12 month follow-up, DMEK eyes had significantly lesser posterior corneal surface and total higher-order aberrations. Compared to baseline, UT-DSAEK eyes experienced an increase in total posterior HOAs at 12 months follow-up, while it was reversed for the DMEK eyes |
| Ang MJ et al./2019 | 50 | RCT | FECD and PBK | UT-DSAEK and DMEK | Improvement in vision-related quality of life was found to be comparable among the two groups |
| Chamberlain W et al./2018 | 50 | RCT | FECD and PBK | UT-DSAEK (n=25) vs DMEK (25) | DMEK eyes had significantly better visual acuity at 3, 6, and 12 months follow up. Endothelial cell counts and complication rates were similar till 12 months follow-up |
Footnote: N – Total number of eyes enrolled, R – Retrospective, DMEK – Descemet membrane endothelial keratoplasty, UT-DSAEK – Ultrathin Descemet stripping automated endothelial keratoplasty, DSAEK – Descemet stripping automated endothelial keratoplasty, RCT – Randomized-controlled trial, FECD – Fuchs endothelial corneal dystrophy, BSCVA – Best spectacle-corrected visual acuity, PBK – Pseudophakic Bullous Keratopathy, ECD – Endothelial cell density, CH – corneal hysteresis, CRF – Corneal resistance factor
Conclusion
The current review summarizes preoperative considerations, intraoperative nuances of different surgical techniques, and postoperative outcomes of DMEK. The review summarizes the advantages and disadvantages of different surgical modifications and enables us to customize surgical techniques keeping in mind the associated outcomes of each technique.
Financial support and sponsorship
Nil.
Conflicts of interest
There are no conflicts of interest.
References
- 1.Yeu E, Gomes JAP, Ayres B, Chan CC, Gupta PK, Beckman KA, et al. Posterior lamellar keratoplasty:Techniques, outcomes, and recent advances. J Cataract Refract Surg. 2021;47:1345–59. doi: 10.1097/j.jcrs.0000000000000634. [DOI] [PubMed] [Google Scholar]
- 2.Okumura N, Kinoshita S, Koizumi N. Application of Rho kinase inhibitors for the treatment of corneal endothelial diseases. J Ophthalmol. 2017;2017:2646904. doi: 10.1155/2017/2646904. doi:10.1155/2017/2646904. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 3.Okumura N, Sakamoto Y, Fujii K, Kitano J, Nakano S, Tsujimoto Y, et al. Rho kinase inhibitor enables cell-based therapy for corneal endothelial dysfunction. Sci Rep. 2016;6:26113. doi: 10.1038/srep26113. doi:10.1038/srep26113. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 4.Heinzelmann S, Hüther S, Böhringer D, Eberwein P, Reinhard T, Maier P. Influence of donor characteristics on Descemet membrane endothelial keratoplasty. Cornea. 2014;33:644–8. doi: 10.1097/ICO.0000000000000106. [DOI] [PubMed] [Google Scholar]
- 5.Schaub F, Enders P, Zachewicz J, Heindl LM, Stanzel TP, Cursiefen C, et al. Impact of Donor age on Descemet membrane endothelial keratoplasty outcome:Evaluation of donors aged 17-55 years. Am J Ophthalmol. 2016;170:119–27. doi: 10.1016/j.ajo.2016.08.005. [DOI] [PubMed] [Google Scholar]
- 6.Greiner MA, Rixen JJ, Wagoner MD, Schmidt GA, Stoeger CG, Straiko MD, et al. Diabetes mellitus increases risk of unsuccessful graft preparation in Descemet membrane endothelial keratoplasty:A multicenter study. Cornea. 2014;33:1129–33. doi: 10.1097/ICO.0000000000000262. [DOI] [PubMed] [Google Scholar]
- 7.Schwarz C, Aldrich BT, Burckart KA, Schmidt GA, Zimmerman MB, Reed CR, et al. Descemet membrane adhesion strength is greater in diabetics with advanced disease compared to healthy donor corneas. Exp Eye Res. 2016;153:152–8. doi: 10.1016/j.exer.2016.10.015. [DOI] [PubMed] [Google Scholar]
- 8.Luke W, Tamme G-H, Yee Chen J, Richard M. Corneal donor characteristics and Descemet membrane endothelial keratoplasty success:A scoping review. Cornea. 2021;40:930–5. doi: 10.1097/ICO.0000000000002682. [DOI] [PubMed] [Google Scholar]
- 9.Straiko MD, Bauer AJ, Straiko MMW, Potts LB, Chen S-Y, Tran KD, et al. Donor DMEK tissue characteristics:Association with rebubble rate and 6-month endothelial cell loss. Cornea. 2020;39:1267–73. doi: 10.1097/ICO.0000000000002398. [DOI] [PubMed] [Google Scholar]
- 10.Deng SX, Lee WB, Hammersmith KM, Kuo AN, Li JY, Shen JF, et al. Descemet membrane endothelial keratoplasty:Safety and outcomes:A report by the American Academy of Ophthalmology. Ophthalmology. 2018;125:295–310. doi: 10.1016/j.ophtha.2017.08.015. [DOI] [PubMed] [Google Scholar]
- 11.Parekh M, Leon P, Ruzza A, Borroni D, Ferrari S, Ponzin D, et al. Graft detachment and rebubbling rate in Descemet membrane endothelial keratoplasty. Surv Ophthalmol. 2018;63:245–50. doi: 10.1016/j.survophthal.2017.07.003. [DOI] [PubMed] [Google Scholar]
- 12.Dirisamer M, van Dijk K, Dapena I, Ham L, Oganes O, Frank LE, et al. Prevention and management of graft detachment in Descemet membrane endothelial keratoplasty. Arch Ophthalmol. 2012;130:280–91. doi: 10.1001/archophthalmol.2011.343. [DOI] [PubMed] [Google Scholar]
- 13.Lavy I, Liarakos VS, Verdijk RM, Parker J, Müller TM, Bruinsma M, et al. Outcome and histopathology of secondary penetrating keratoplasty graft failure managed by Descemet membrane endothelial keratoplasty. Cornea. 2017;36:777–84. doi: 10.1097/ICO.0000000000001180. [DOI] [PubMed] [Google Scholar]
- 14.Birbal RS, Sikder S, Lie JT, Groeneveld-van Beek EA, Oellerich S, Melles GRJ. Donor tissue preparation for Descemet membrane endothelial keratoplasty:An updated review. Cornea. 2018;37:128–35. doi: 10.1097/ICO.0000000000001368. [DOI] [PubMed] [Google Scholar]
- 15.Melles GRJ, Lander F, Rietveld FJR. Transplantation of Descemet's membrane carrying viable endothelium through a small scleral incision. Cornea. 2002;21:415–8. doi: 10.1097/00003226-200205000-00016. [DOI] [PubMed] [Google Scholar]
- 16.Zhu Z, Rife L, Yiu S, Trousdale MD, Wasilewski D, Siqueira A, et al. Technique for preparation of the corneal endothelium-Descemet membrane complex for transplantation. Cornea. 2006;25:705–8. doi: 10.1097/01.ico.0000214229.21238.eb. [DOI] [PubMed] [Google Scholar]
- 17.Lie JT, Birbal R, Ham L, van der Wees J, Melles GRJ. Donor tissue preparation for Descemet membrane endothelial keratoplasty. J Cataract Refract Surg. 2008;34:1578–83. doi: 10.1016/j.jcrs.2008.05.036. [DOI] [PubMed] [Google Scholar]
- 18.Groeneveld-van Beek EA, Lie JT, van der Wees J, Bruinsma M, Melles GRJ. Standardized “no-touch”donor tissue preparation for DALK and DMEK:Harvesting undamaged anterior and posterior transplants from the same donor cornea. Acta Ophthalmol. 2013;91:145–50. doi: 10.1111/j.1755-3768.2012.02462.x. [DOI] [PubMed] [Google Scholar]
- 19.Price MO, Giebel AW, Fairchild KM, Price FW. Descemet's membrane endothelial keratoplasty:Prospective multicenter study of visual and refractive outcomes and endothelial survival. Ophthalmology. 2009;116:2361–8. doi: 10.1016/j.ophtha.2009.07.010. [DOI] [PubMed] [Google Scholar]
- 20.Tenkman LR, Price FW, Price MO. Descemet membrane endothelial keratoplasty donor preparation:Navigating challenges and improving efficiency. Cornea. 2014;33:319–25. doi: 10.1097/ICO.0000000000000045. [DOI] [PubMed] [Google Scholar]
- 21.Kruse FE, Laaser K, Cursiefen C, Heindl LM, Schlötzer-Schrehardt U, Riss S, et al. A stepwise approach to donor preparation and insertion increases safety and outcome of Descemet membrane endothelial keratoplasty. Cornea. 2011;30:580–7. doi: 10.1097/ico.0b013e3182000e2e. [DOI] [PubMed] [Google Scholar]
- 22.Yoeruek E, Bartz-Schmidt K-U, Schmidt B. Novel surgical instruments facilitating Descemet membrane dissection. Cornea. 2013;32:523–6. doi: 10.1097/ICO.0b013e3182588ae9. [DOI] [PubMed] [Google Scholar]
- 23.Sikder S, Ward D, Jun AS. A surgical technique for donor tissue harvesting for Descemet membrane endothelial keratoplasty. Cornea. 2011;30:91–4. doi: 10.1097/ICO.0b013e3181e2957b. [DOI] [PubMed] [Google Scholar]
- 24.Tausif HN, Johnson L, Titus M, Mavin K, Chandrasekaran N, Woodward MA, et al. Corneal donor tissue preparation for Descemet's membrane endothelial keratoplasty. J Vis Exp. 2014;51919 doi: 10.3791/51919. doi:10.3791/51919. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 25.Maharana PK, Sahay P, Titiyal JS, Sharma N. Sinsky hook assisted roll preparation (SHARP):A modified technique for Descemet membrane endothelial keratoplasty donor preparation. Saudi J Ophthalmol. 2019;33:28–33. doi: 10.1016/j.sjopt.2018.12.002. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 26.Tzamalis A, Vinciguerra R, Romano V, Arbabi E, Borroni D, Wojcik G, et al. The “Yogurt”technique for Descemet membrane endothelial keratoplasty graft preparation:A novel quick and safe method for both inexperienced and senior surgeons. Cornea. 2020;39:1190–5. doi: 10.1097/ICO.0000000000002401. [DOI] [PubMed] [Google Scholar]
- 27.Anwar M, Teichmann KD. Big-bubble technique to bare Descemet's membrane in anterior lamellar keratoplasty. J Cataract Refract Surg. 2002;28:398–403. doi: 10.1016/s0886-3350(01)01181-6. [DOI] [PubMed] [Google Scholar]
- 28.Busin M, Scorcia V, Patel AK, Salvalaio G, Ponzin D. Pneumatic dissection and storage of donor endothelial tissue for Descemet's membrane endothelial keratoplasty:A novel technique. Ophthalmology. 2010;117:1517–20. doi: 10.1016/j.ophtha.2009.12.040. [DOI] [PubMed] [Google Scholar]
- 29.Venzano D, Pagani P, Randazzo N, Cabiddu F, Traverso CE. Descemet membrane air-bubble separation in donor corneas. J Cataract Refract Surg. 2010;36:2022–7. doi: 10.1016/j.jcrs.2010.10.013. [DOI] [PubMed] [Google Scholar]
- 30.Studeny P, Farkas A, Vokrojova M, Liskova P, Jirsova K. Descemet membrane endothelial keratoplasty with a stromal rim (DMEK-S) Br J Ophthalmol. 2010;94:909–14. doi: 10.1136/bjo.2009.165134. [DOI] [PubMed] [Google Scholar]
- 31.Agarwal A, Dua HS, Narang P, Kumar DA, Agarwal A, Jacob S, et al. Pre-Descemet's endothelial keratoplasty (PDEK) Br J Ophthalmol. 2014;98:1181–5. doi: 10.1136/bjophthalmol-2013-304639. [DOI] [PubMed] [Google Scholar]
- 32.Muraine M, Gueudry J, He Z, Piselli S, Lefevre S, Toubeau D. Novel technique for the preparation of corneal grafts for Descemet membrane endothelial keratoplasty. Am J Ophthalmol. 2013;156:851–9. doi: 10.1016/j.ajo.2013.05.041. [DOI] [PubMed] [Google Scholar]
- 33.Salvalaio G, Parekh M, Ruzza A, Ferrari S, Camposampiero D, Ponzin D. DMEK lenticule preparation from donor corneas using a novel “SubHyS”technique followed by anterior corneal dissection. Br J Ophthalmol. 2014;98:1120–5. doi: 10.1136/bjophthalmol-2013-304466. [DOI] [PubMed] [Google Scholar]
- 34.Szurman P, Januschowski K, Rickmann A, Damm L-J, Boden KT, Opitz N. Novel liquid bubble dissection technique for DMEK lenticule preparation. Graefes Arch Clin Exp Ophthalmol. 2016;254:1819–23. doi: 10.1007/s00417-016-3377-z. [DOI] [PubMed] [Google Scholar]
- 35.Güell JL, Morral M, Gris O, Elies D, Manero F. Bimanual technique for insertion and positioning of endothelium-Descemet membrane graft in Descemet membrane endothelial keratoplasty. Cornea. 2013;32:1521–6. doi: 10.1097/ICO.0b013e3182933aee. [DOI] [PubMed] [Google Scholar]
- 36.Monnereau C, Quilendrino R, Dapena I, Liarakos VS, Alfonso JF, Arnalich-Montiel F, et al. Multicenter study of Descemet membrane endothelial keratoplasty:First case series of 18 surgeons. JAMA Ophthalmol. 2014;132:1192–8. doi: 10.1001/jamaophthalmol.2014.1710. [DOI] [PubMed] [Google Scholar]
- 37.Ang M, Mehta JS, Newman SD, Han SB, Chai J, Tan D. Descemet membrane endothelial keratoplasty:Preliminary results of a donor insertion pull-through technique using a donor mat device. Am J Ophthalmol. 2016;171:27–34. doi: 10.1016/j.ajo.2016.08.023. [DOI] [PubMed] [Google Scholar]
- 38.Gabbay IE, Bahar I, Nahum Y, Livny E. Comparison of Descemet stripping under continuous air flow, manual air injection and balanced salt solution for DMEK:A pilot study. Graefes Arch Clin Exp Ophthalmol. 2017;255:1605–11. doi: 10.1007/s00417-017-3675-0. [DOI] [PubMed] [Google Scholar]
- 39.Hayashi T, Oyakawa I, Kato N. Techniques for learning Descemet membrane endothelial keratoplasty for eyes of Asian patients with shallow anterior chamber. Cornea. 2017;36:390–3. doi: 10.1097/ICO.0000000000001093. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 40.Fogla R, Thazethaeveetil IR. A novel technique for donor insertion and unfolding in Descemet membrane endothelial keratoplasty. Cornea. 2021;40:1073–8. doi: 10.1097/ICO.0000000000002698. [DOI] [PubMed] [Google Scholar]
- 41.Ighani M, Karakus S, Eghrari AO. Clinical outcomes of Descemet membrane endothelial keratoplasty using the Bonfadini-Todd injector for graft insertion. Clin Ophthalmol. 2019;13:1869–76. doi: 10.2147/OPTH.S219742. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 42.Price MO, Lisek M, Kelley M, Feng MT, Price FW. Endothelium-in versus endothelium-out insertion with Descemet membrane endothelial keratoplasty. Cornea. 2018;37:1098–101. doi: 10.1097/ICO.0000000000001650. [DOI] [PubMed] [Google Scholar]
- 43.Siebelmann S, Janetzko M, König P, Scholz P, Matthaei M, Händel A, et al. Flushing versus pushing technique for graft implantation in Descemet membrane endothelial keratoplasty. Cornea. 2020;39:605–8. doi: 10.1097/ICO.0000000000002239. [DOI] [PubMed] [Google Scholar]
- 44.Arnalich-Montiel F, Muñoz-Negrete FJ, De Miguel MP. Double port injector device to reduce endothelial damage in DMEK. Eye (Lond) 2014;28:748–51. doi: 10.1038/eye.2014.67. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 45.Kim EC, Bonfadini G, Todd L, Zhu A, Jun AS. Simple, inexpensive, and effective injector for Descemet membrane endothelial keratoplasty. Cornea. 2014;33:649–52. doi: 10.1097/ICO.0000000000000121. [DOI] [PubMed] [Google Scholar]
- 46.Tan T-E, Devarajan K, Seah X-Y, Lin S-J, Peh GSL, Cajucom-Uy HY, et al. Descemet membrane endothelial keratoplasty with a pull-through insertion device:Surgical technique, endothelial cell loss, and early clinical results. Cornea. 2020;39:558–65. doi: 10.1097/ICO.0000000000002268. [DOI] [PubMed] [Google Scholar]
- 47.Woo JH, Htoon HM, Tan D. Hybrid Descemet membrane endothelial keratoplasty (H-DMEK):Results of a donor insertion pull-through technique using donor stroma as carrier. Br J Ophthalmol. 2020;104:1358–62. doi: 10.1136/bjophthalmol-2019-314932. [DOI] [PubMed] [Google Scholar]
- 48.Chong EW, Bandeira F, Finn P, Mehta JS, Chan E. Evaluation of total donor endothelial viability after endothelium-inward versus endothelium-outward loading and insertion in Descemet membrane endothelial keratoplasty. Cornea. 2020;39:104–9. doi: 10.1097/ICO.0000000000002014. [DOI] [PubMed] [Google Scholar]
- 49.Solar SJ, Deljookorani S, Wiener BG, Rosen A, Chaurasia A, Shahmirzadi M, et al. Preloading trifolded grafts for Descemet membrane endothelial keratoplasty affects scroll formation. Cornea. 2020;39:1062–5. doi: 10.1097/ICO.0000000000002298. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 50.Ighani M, Dzhaber D, Jain S, De Rojas JO, Eghrari AO. Techniques, outcomes, and complications of preloaded, trifolded Descemet membrane endothelial keratoplasty using the DMEK EndoGlide. Cornea. 2021;40:669–74. doi: 10.1097/ICO.0000000000002648. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 51.Liarakos VS, Dapena I, Ham L, van Dijk K, Melles GRJ. Intraocular graft unfolding techniques in Descemet membrane endothelial keratoplasty. JAMA Ophthalmol. 2013;131:29–35. doi: 10.1001/2013.jamaophthalmol.4. [DOI] [PubMed] [Google Scholar]
- 52.Dapena I, Moutsouris K, Droutsas K, Ham L, van Dijk K, Melles GRJ. Standardized “no-touch”technique for Descemet membrane endothelial keratoplasty. Arch Ophthalmol. 2011;129:88–94. doi: 10.1001/archophthalmol.2010.334. [DOI] [PubMed] [Google Scholar]
- 53.Rickmann A, Boden K, Trouvain AM, Müller LJ, Bocqué C, Thaler S, et al. Clinical results after single asymmetrical shark fin for graft orientation in DMEK. Int Ophthalmol. 2022;42:1061–8. doi: 10.1007/s10792-021-02091-7. [DOI] [PubMed] [Google Scholar]
- 54.Veldman PB, Dye PK, Holiman JD, Mayko ZM, Sáles CS, Straiko MD, et al. The S-stamp in Descemet membrane endothelial keratoplasty safely eliminates upside-down graft implantation. Ophthalmology. 2016;123:161–4. doi: 10.1016/j.ophtha.2015.08.044. [DOI] [PubMed] [Google Scholar]
- 55.Matsuzawa A, Hayashi T, Oyakawa I, Yuda K, Shimizu T, Mizuki N, et al. Use of four asymmetric marks to orient the donor graft during Descemet's membrane endothelial keratoplasty. BMJ Open Ophthalmol. 2017;1:e000080. doi: 10.1136/bmjophth-2017-000080. doi:10.1136/bmjophth-2017-000080. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 56.Livny E, Bahar I, Nahum Y. “Ghost DMEK”Technique:Circular peripheral staining of Descemet's membrane endothelial keratoplasty grafts. Cornea. 2019;38:252–5. doi: 10.1097/ICO.0000000000001816. [DOI] [PubMed] [Google Scholar]
- 57.Kobayashi A, Yokogawa H, Mori N, Masaki T, Sugiyama K. Development of a donor tissue holding technique for Descemet's membrane endothelial keratoplasty using a 25-gauge graft manipulator. Case Rep Ophthalmol. 2018;9:431–8. doi: 10.1159/000493571. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 58.Nahum Y, Galor O, Atar M, Bahar I, Livny E. Real-time intraoperative ultrasound biomicroscopy for determining graft orientation during Descemet's membrane endothelial keratoplasty. Acta Ophthalmol. 2021;99:e96–100. doi: 10.1111/aos.14515. [DOI] [PubMed] [Google Scholar]
- 59.Patel AS, Goshe JM, Srivastava SK, Ehlers JP. Intraoperative optical coherence tomography-assisted Descemet membrane endothelial keratoplasty in the DISCOVER study:First 100 cases. Am J Ophthalmol. 2020;210:167–73. doi: 10.1016/j.ajo.2019.09.018. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 60.Steven P, Le Blanc C, Velten K, Lankenau E, Krug M, Oelckers S, et al. Optimizing Descemet membrane endothelial keratoplasty using intraoperative optical coherence tomography. JAMA Ophthalmol. 2013;131:1135–42. doi: 10.1001/jamaophthalmol.2013.4672. [DOI] [PubMed] [Google Scholar]
- 61.Sharma N, Sahay P, Maharana PK, Kumar P, Ahsan S, Titiyal JS. Microscope Integrated Intraoperative optical coherence tomography-guided DMEK in corneas with poor visualization. Clin Ophthalmol. 2020;14:643–51. doi: 10.2147/OPTH.S230195. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 62.Guerra FP, Anshu A, Price MO, Price FW. Endothelial keratoplasty:Fellow eyes comparison of Descemet stripping automated endothelial keratoplasty and Descemet membrane endothelial keratoplasty. Cornea. 2011;30:1382–6. doi: 10.1097/ICO.0b013e31821ddd25. [DOI] [PubMed] [Google Scholar]
- 63.Guerra FP, Anshu A, Price MO, Giebel AW, Price FW. Descemet's membrane endothelial keratoplasty:Prospective study of 1-year visual outcomes, graft survival, and endothelial cell loss. Ophthalmology. 2011;118:2368–73. doi: 10.1016/j.ophtha.2011.06.002. [DOI] [PubMed] [Google Scholar]
- 64.Ang M, Wilkins MR, Mehta JS, Tan D. Descemet membrane endothelial keratoplasty. Br J Ophthalmol. 2016;100:15–21. doi: 10.1136/bjophthalmol-2015-306837. [DOI] [PubMed] [Google Scholar]
- 65.Melles GRJ, Ong TS, Ververs B, van der Wees J. Preliminary clinical results of Descemet membrane endothelial keratoplasty. Am J Ophthalmol. 2008;145:222–7. doi: 10.1016/j.ajo.2007.09.021. [DOI] [PubMed] [Google Scholar]
- 66.Quilendrino R, Rodriguez-Calvo de Mora M, Baydoun L, Ham L, van Dijk K, Dapena I, et al. Prevention and management of Descemet membrane endothelial keratoplasty complications. Cornea. 2017;36:1089–95. doi: 10.1097/ICO.0000000000001262. [DOI] [PubMed] [Google Scholar]
- 67.Ampazas P, Droutsas K, Giallouros E, Schroeder FM, Sekundo W. Comparison of 5% Sulfur Hexafluoride Versus 100% Air Tamponade in Descemet Membrane Endothelial Keratoplasty. Cornea. 2017;36:1189–94. doi: 10.1097/ICO.0000000000001299. [DOI] [PubMed] [Google Scholar]
- 68.Müller TM, Verdijk RM, Lavy I, Bruinsma M, Parker J, Binder PS, et al. Histopathologic features of Descemet membrane endothelial keratoplasty graft remnants, folds, and detachments. Ophthalmology. 2016;123:2489–97. doi: 10.1016/j.ophtha.2016.08.014. [DOI] [PubMed] [Google Scholar]
- 69.Brockmann T, Brockmann C, Maier A-K, Schroeter J, Pleyer U, Bertelmann E, et al. Clinicopathology of graft detachment after Descemet's membrane endothelial keratoplasty. Acta Ophthalmol. 2014;92:e556–61. doi: 10.1111/aos.12419. [DOI] [PubMed] [Google Scholar]
- 70.Terry MA, Straiko MD, Veldman PB, Talajic JC, VanZyl C, Sales CS, et al. Standardized DMEK technique:Reducing complications using prestripped tissue, novel glass injector, and sulfur hexafluoride (SF6) gas. Cornea. 2015;34:845–52. doi: 10.1097/ICO.0000000000000479. [DOI] [PubMed] [Google Scholar]
- 71.Oellerich S, Baydoun L, Peraza-Nieves J, Ilyas A, Frank L, Binder PS, et al. Multicenter study of 6-month clinical outcomes after Descemet membrane endothelial keratoplasty. Cornea. 2017;36:1467–76. doi: 10.1097/ICO.0000000000001374. [DOI] [PubMed] [Google Scholar]
- 72.Rodríguez-Calvo de Mora M, Groeneveld-van Beek EA, Frank LE, van der Wees J, Oellerich S, Bruinsma M, et al. Association between graft storage time and donor age with endothelial cell density and graft adherence after Descemet membrane endothelial keratoplasty. JAMA Ophthalmol. 2016;134:91–4. doi: 10.1001/jamaophthalmol.2015.4499. [DOI] [PubMed] [Google Scholar]
- 73.Sáles CS, Terry MA, Veldman PB, Mayko ZM, Straiko MD. Relationship between tissue unscrolling time and endothelial cell loss. Cornea. 2016;35:471–6. doi: 10.1097/ICO.0000000000000771. [DOI] [PubMed] [Google Scholar]
- 74.Deng SX, Sanchez PJ, Chen L. Clinical outcomes of Descemet membrane endothelial keratoplasty using eye bank-prepared tissues. Am J Ophthalmol. 2015;159:590–6. doi: 10.1016/j.ajo.2014.12.007. [DOI] [PubMed] [Google Scholar]
- 75.Regnier M, Auxenfans C, Maucort-Boulch D, Marty A-S, Damour O, Burillon C, et al. Eye bank prepared versus surgeon cut endothelial graft tissue for Descemet membrane endothelial keratoplasty:An observational study. Medicine (Baltimore) 2017;96:e6885. doi: 10.1097/MD.0000000000006885. doi:10.1097/MD.0000000000006885. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 76.Feng MT, Burkhart ZN, Price FW, Price MO. Effect of donor preparation-to-use times on Descemet membrane endothelial keratoplasty outcomes. Cornea. 2013;32:1080–2. doi: 10.1097/ICO.0b013e318292a7e5. [DOI] [PubMed] [Google Scholar]
- 77.Yeh R-Y, Quilendrino R, Musa FU, Liarakos VS, Dapena I, Melles GRJ. Predictive value of optical coherence tomography in graft attachment after Descemet's membrane endothelial keratoplasty. Ophthalmology. 2013;120:240–5. doi: 10.1016/j.ophtha.2012.08.011. [DOI] [PubMed] [Google Scholar]
- 78.Güell JL, Morral M, Gris O, Elies D, Manero F. Comparison of sulfur hexafluoride 20% versus air tamponade in Descemet membrane endothelial keratoplasty. Ophthalmology. 2015;122:1757–64. doi: 10.1016/j.ophtha.2015.05.013. [DOI] [PubMed] [Google Scholar]
- 79.Botsford B, Vedana G, Cope L, Yiu SC, Jun AS. Comparison of 20% sulfur hexafluoride with air for intraocular tamponade in Descemet membrane endothelial keratoplasty (DMEK) Arq Bras Oftalmol. 2016;79:299–302. doi: 10.5935/0004-2749.20160086. [DOI] [PubMed] [Google Scholar]
- 80.Schaub F, Enders P, Snijders K, Schrittenlocher S, Siebelmann S, Heindl LM, et al. One-year outcome after Descemet membrane endothelial keratoplasty (DMEK) comparing sulfur hexafluoride (SF6) 20% versus 100% air for anterior chamber tamponade. Br J Ophthalmol. 2017;101:902–8. doi: 10.1136/bjophthalmol-2016-309653. [DOI] [PubMed] [Google Scholar]
- 81.Acar BT, Muftuoglu O, Acar S. Comparison of sulfur hexafluoride and air for donor attachment in Descemet stripping endothelial keratoplasty in patients with pseudophakic bullous keratopathy. Cornea. 2014;33:219–22. doi: 10.1097/ICO.0000000000000049. [DOI] [PubMed] [Google Scholar]
- 82.Marcon AS, Rapuano CJ, Jones MR, Laibson PR, Cohen EJ. Descemet's membrane detachment after cataract surgery:Management and outcome. Ophthalmology. 2002;109:2325–30. doi: 10.1016/s0161-6420(02)01288-5. [DOI] [PubMed] [Google Scholar]
- 83.Feng MT, Price MO, Miller JM, Price FW. Air reinjection and endothelial cell density in Descemet membrane endothelial keratoplasty:Five-year follow-up. J Cataract Refract Surg. 2014;40:1116–21. doi: 10.1016/j.jcrs.2014.04.023. [DOI] [PubMed] [Google Scholar]
- 84.Ćirković A, Schlötzer-Schrehardt U, Weller JM, Kruse FE, Tourtas T. Clinical and ultrastructural characteristics of graft failure in DMEK:1-year results after repeat DMEK. Cornea. 2015;34:11–7. doi: 10.1097/ICO.0000000000000295. [DOI] [PubMed] [Google Scholar]
- 85.Maier A-KB, Wolf T, Gundlach E, Klamann MKJ, Gonnermann J, Bertelmann E, et al. Intraocular pressure elevation and post-DMEK glaucoma following Descemet membrane endothelial keratoplasty. Graefes Arch Clin Exp Ophthalmol. 2014;252:1947–54. doi: 10.1007/s00417-014-2757-5. [DOI] [PubMed] [Google Scholar]
- 86.Naveiras M, Dirisamer M, Parker J, Ham L, van Dijk K, Dapena I, et al. Causes of glaucoma after Descemet membrane endothelial keratoplasty. Am J Ophthalmol. 2012;153:958–66.e1. doi: 10.1016/j.ajo.2011.10.003. [DOI] [PubMed] [Google Scholar]
- 87.Aravena C, Yu F, Deng SX. Outcomes of Descemet membrane endothelial keratoplasty in patients with previous glaucoma surgery. Cornea. 2017;36:284–9. doi: 10.1097/ICO.0000000000001095. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 88.Gonzalez A, Price FW, Jr, Price MO, Feng MT. Prevention and management of pupil block after Descemet membrane endothelial keratoplasty. Cornea. 2016;35:1391–5. doi: 10.1097/ICO.0000000000001015. doi:10.1097/ICO.0000000000001015. [DOI] [PubMed] [Google Scholar]
- 89.Chaurasia S, Price FW, Gunderson L, Price MO. Descemet's membrane endothelial keratoplasty:Clinical results of single versus triple procedures (combined with cataract surgery) Ophthalmology. 2014;121:454–8. doi: 10.1016/j.ophtha.2013.09.032. [DOI] [PubMed] [Google Scholar]
- 90.Röck D, Bartz-Schmidt KU, Röck T, Yoeruek E. Air bubble-induced high intraocular pressure after Descemet membrane endothelial keratoplasty. Cornea. 2016;35:1035–9. doi: 10.1097/ICO.0000000000000901. [DOI] [PubMed] [Google Scholar]
- 91.Vajaranant TS, Price MO, Price FW, Gao W, Wilensky JT, Edward DP. Visual acuity and intraocular pressure after Descemet's stripping endothelial keratoplasty in eyes with and without preexisting glaucoma. Ophthalmology. 2009;116:1644–50. doi: 10.1016/j.ophtha.2009.05.034. [DOI] [PubMed] [Google Scholar]
- 92.Price MO, Scanameo A, Feng MT, Price FW. Descemet's membrane endothelial keratoplasty:Risk of immunologic rejection episodes after discontinuing topical corticosteroids. Ophthalmology. 2016;123:1232–6. doi: 10.1016/j.ophtha.2016.02.001. [DOI] [PubMed] [Google Scholar]
- 93.Price MO, Price FW, Kruse FE, Bachmann BO, Tourtas T. Randomized comparison of topical prednisolone acetate 1% versus fluorometholone 0.1% in the first year after Descemet membrane endothelial keratoplasty. Cornea. 2014;33:880–6. doi: 10.1097/ICO.0000000000000206. [DOI] [PubMed] [Google Scholar]
- 94.Price MO, Feng MT, Scanameo A, Price FW. Loteprednol etabonate 0.5% gel vs. prednisolone acetate 1% solution after Descemet membrane endothelial keratoplasty:Prospective randomized trial. Cornea. 2015;34:853–8. doi: 10.1097/ICO.0000000000000475. [DOI] [PubMed] [Google Scholar]
- 95.Dapena I, Ham L, Netuková M, van der Wees J, Melles GRJ. Incidence of early allograft rejection after Descemet membrane endothelial keratoplasty. Cornea. 2011;30:1341–5. doi: 10.1097/ICO.0b013e31820d8540. [DOI] [PubMed] [Google Scholar]
- 96.Thompson RW, Price MO, Bowers PJ, Price FW. Long-term graft survival after penetrating keratoplasty. Ophthalmology. 2003;110:1396–402. doi: 10.1016/S0161-6420(03)00463-9. [DOI] [PubMed] [Google Scholar]
- 97.Dua HS, Azuara-Blanco A. Corneal allograft rejection:Risk factors, diagnosis, prevention, and treatment. Indian J Ophthalmol. 1999;47:3–9. [PubMed] [Google Scholar]
- 98.Maguire MG, Stark WJ, Gottsch JD, Stulting RD, Sugar A, Fink NE, et al. Risk factors for corneal graft failure and rejection in the collaborative corneal transplantation studies. Collaborative Corneal Transplantation Studies Research Group. Ophthalmology. 1994;101:1536–47. doi: 10.1016/s0161-6420(94)31138-9. [DOI] [PubMed] [Google Scholar]
- 99.Claesson M, Armitage WJ, Fagerholm P, Stenevi U. Visual outcome in corneal grafts:A preliminary analysis of the Swedish corneal transplant register. Br J Ophthalmol. 2002;86:174–80. doi: 10.1136/bjo.86.2.174. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 100.Williams KA, Muehlberg SM, Lewis RF, Coster DJ. How successful is corneal transplantation?A report from the Australian corneal graft register. Eye (Lond) 1995;9:219–27. doi: 10.1038/eye.1995.43. [DOI] [PubMed] [Google Scholar]
- 101.Coster DJ, Williams KA. The impact of corneal allograft rejection on the long-term outcome of corneal transplantation. Am J Ophthalmol. 2005;140:1112–22. doi: 10.1016/j.ajo.2005.07.024. [DOI] [PubMed] [Google Scholar]
- 102.Küchle M, Cursiefen C, Nguyen NX, Langenbucher A, Seitz B, Wenkel H, et al. Risk factors for corneal allograft rejection:Intermediate results of a prospective normal-risk keratoplasty study. Graefes Arch Clin Exp Ophthalmol. 2002;240:580–4. doi: 10.1007/s00417-002-0496-5. [DOI] [PubMed] [Google Scholar]
- 103.Allan BDS, Terry MA, Price FW, Price MO, Griffin NB, Claesson M. Corneal transplant rejection rate and severity after endothelial keratoplasty. Cornea. 2007;26:1039–42. doi: 10.1097/ICO.0b013e31812f66e5. [DOI] [PubMed] [Google Scholar]
- 104.Koenig SB, Covert DJ, Dupps WJ, Meisler DM. Visual acuity, refractive error, and endothelial cell density six months after Descemet stripping and automated endothelial keratoplasty (DSAEK) Cornea. 2007;26:670–4. doi: 10.1097/ICO.0b013e3180544902. [DOI] [PubMed] [Google Scholar]
- 105.Price MO, Jordan CS, Moore G, Price FW. Graft rejection episodes after Descemet stripping with endothelial keratoplasty:Part two:The statistical analysis of probability and risk factors. Br J Ophthalmol. 2009;93:391–5. doi: 10.1136/bjo.2008.140038. [DOI] [PubMed] [Google Scholar]
- 106.Lee WB, Jacobs DS, Musch DC, Kaufman SC, Reinhart WJ, Shtein RM. Descemet's stripping endothelial keratoplasty:Safety and outcomes:A report by the American Academy of Ophthalmology. Ophthalmology. 2009;116:1818–30. doi: 10.1016/j.ophtha.2009.06.021. [DOI] [PubMed] [Google Scholar]
- 107.Hori J, Joyce NC, Streilein JW. Immune privilege and immunogenicity reside among different layers of the mouse cornea 2000. Ocul Immunol Inflamm. 2007;15:225–39. doi: 10.1080/09273940701382374. [DOI] [PubMed] [Google Scholar]
- 108.Heinzelmann S, Böhringer D, Eberwein P, Reinhard T, Maier P. Outcomes of Descemet membrane endothelial keratoplasty, Descemet stripping automated endothelial keratoplasty and penetrating keratoplasty from a single centre study. Graefes Arch Clin Exp Ophthalmol. 2016;254:515–22. doi: 10.1007/s00417-015-3248-z. [DOI] [PubMed] [Google Scholar]
- 109.Anshu A, Price MO, Price FW. Risk of corneal transplant rejection significantly reduced with Descemet's membrane endothelial keratoplasty. Ophthalmology. 2012;119:536–40. doi: 10.1016/j.ophtha.2011.09.019. [DOI] [PubMed] [Google Scholar]
- 110.Hos D, Tuac O, Schaub F, Stanzel TP, Schrittenlocher S, Hellmich M, et al. Incidence and clinical course of immune reactions after Descemet membrane endothelial keratoplasty:Retrospective analysis of 1000 consecutive eyes. Ophthalmology. 2017;124:512–8. doi: 10.1016/j.ophtha.2016.12.017. [DOI] [PubMed] [Google Scholar]
- 111.Baydoun L, Livny E, Ham L, Bruinsma M, Melles GRJ. 360-degree scheimpflug imaging to predict allograft rejection after Descemet membrane endothelial keratoplasty. Cornea. 2016;35:1385–90. doi: 10.1097/ICO.0000000000001007. [DOI] [PubMed] [Google Scholar]
- 112.Monnereau C, Bruinsma M, Ham L, Baydoun L, Oellerich S, Melles GRJ. Endothelial cell changes as an indicator for upcoming allograft rejection following Descemet membrane endothelial keratoplasty. Am J Ophthalmol. 2014;158:485–95. doi: 10.1016/j.ajo.2014.05.030. [DOI] [PubMed] [Google Scholar]
- 113.Yoeruek E, Hofmann J, Bartz-Schmidt K-U. Histological and ultrastructural findings of corneal tissue after failed Descemet membrane endothelial keratoplasty. Acta Ophthalmol. 2014;92:e213–6. doi: 10.1111/aos.12116. [DOI] [PubMed] [Google Scholar]
- 114.Heinzelmann S, Böhringer D, Eberwein P, Reinhard T, Maier P. Graft dislocation and graft failure following Descemet membrane endothelial keratoplasty (DMEK) using precut tissue:A retrospective cohort study. Graefes Arch Clin Exp Ophthalmol. 2017;255:127–33. doi: 10.1007/s00417-016-3499-3. [DOI] [PubMed] [Google Scholar]
- 115.Pavlovic I, Shajari M, Herrmann E, Schmack I, Lencova A, Kohnen T. Meta-analysis of postoperative outcome parameters comparing Descemet membrane endothelial keratoplasty versus Descemet stripping automated endothelial keratoplasty. Cornea. 2017;36:1445–51. doi: 10.1097/ICO.0000000000001384. [DOI] [PubMed] [Google Scholar]
- 116.Debellemanière G, Guilbert E, Courtin R, Panthier C, Sabatier P, Gatinel D, et al. Impact of surgical learning curve in Descemet membrane endothelial keratoplasty on visual acuity gain. Cornea. 2017;36:1–6. doi: 10.1097/ICO.0000000000001066. doi:10.1097/ICO.0000000000001066. [DOI] [PubMed] [Google Scholar]
- 117.Holtmann C, Spaniol K, Geerling G. Urrets-Zavalia syndrome after Descemet membrane endothelial keratoplasty. Eur J Ophthalmol. 2015;25:e75–7. doi: 10.5301/ejo.5000597. [DOI] [PubMed] [Google Scholar]
- 118.Phillips PM, Phillips LJ, Muthappan V, Maloney CM, Carver CN. Experienced DSAEK surgeon's transition to DMEK:Outcomes comparing the last 100 DSAEK surgeries with the first 100 DMEK surgeries exclusively using previously published techniques. Cornea. 2017;36:275–9. doi: 10.1097/ICO.0000000000001069. [DOI] [PubMed] [Google Scholar]
- 119.Arnalich-Montiel F, Pérez-Sarriegui A, Lauzirika G, Porrua L, Hernández-Verdejo JL. Pupillary abnormalities in Descemet membrane endothelial keratoplasty after nearly full tamponade. Cornea. 2017;36:290–4. doi: 10.1097/ICO.0000000000001141. [DOI] [PubMed] [Google Scholar]
- 120.Schlögl A, Tourtas T, Kruse FE, Weller JM. Long-term clinical outcome after Descemet membrane endothelial keratoplasty. Am J Ophthalmol. 2016;169:218–26. doi: 10.1016/j.ajo.2016.07.002. [DOI] [PubMed] [Google Scholar]
- 121.Heinzelmann S, Maier P, Böhringer D, Hüther S, Eberwein P, Reinhard T. Cystoid macular oedema following Descemet membrane endothelial keratoplasty. Br J Ophthalmol. 2015;99:98–102. doi: 10.1136/bjophthalmol-2014-305124. [DOI] [PubMed] [Google Scholar]
- 122.Flanary WE, Vislisel JM, Wagoner MD, Raecker ME, Aldrich BT, Zimmerman MB, et al. Incidence of cystoid macular edema after Descemet membrane endothelial keratoplasty as a staged and solitary procedure. Cornea. 2016;35:1040–4. doi: 10.1097/ICO.0000000000000870. [DOI] [PubMed] [Google Scholar]
- 123.Hoerster R, Stanzel TP, Bachmann BO, Siebelmann S, Felsch M, Cursiefen C. Intensified topical steroids as prophylaxis for macular edema after posterior lamellar keratoplasty combined with cataract surgery. Am J Ophthalmol. 2016;163:174–9.e2. doi: 10.1016/j.ajo.2015.12.008. [DOI] [PubMed] [Google Scholar]
- 124.Parker J, Dirisamer M, Naveiras M, Tse WHW, van Dijk K, Frank LE, et al. Outcomes of Descemet membrane endothelial keratoplasty in phakic eyes. J Cataract Refract Surg. 2012;38:871–7. doi: 10.1016/j.jcrs.2011.11.038. [DOI] [PubMed] [Google Scholar]
- 125.Burkhart ZN, Feng MT, Price FW, Price MO. One-year outcomes in eyes remaining phakic after Descemet membrane endothelial keratoplasty. J Cataract Refract Surg. 2014;40:430–4. doi: 10.1016/j.jcrs.2013.08.047. [DOI] [PubMed] [Google Scholar]
- 126.Musa FU, Cabrerizo J, Quilendrino R, Dapena I, Ham L, Melles GRJ. Outcomes of phacoemulsification after Descemet membrane endothelial keratoplasty. J Cataract Refract Surg. 2013;39:836–40. doi: 10.1016/j.jcrs.2012.12.032. [DOI] [PubMed] [Google Scholar]
- 127.Mojzis P, Studeny P, Werner L, Piñero DP. Opacification of a hydrophilic acrylic intraocular lens with a hydrophobic surface after air injection in Descemet-stripping automated endothelial keratoplasty in a patient with Fuchs dystrophy. J Cataract Refract Surg. 2016;42:485–8. doi: 10.1016/j.jcrs.2016.02.004. [DOI] [PubMed] [Google Scholar]
- 128.Giers BC, Tandogan T, Auffarth GU, Choi CY, Auerbach FN, Sel S, et al. Hydrophilic intraocular lens opacification after posterior lamellar keratoplasty-a material analysis with special reference to optical quality assessment. BMC Ophthalmol. 2017;17:150. doi: 10.1186/s12886-017-0546-8. doi:10.1186/s12886-017-0546-8. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 129.Tandogan T, Khoramnia R, Choi CY, Scheuerle A, Wenzel M, Hugger P, et al. Optical and material analysis of opacified hydrophilic intraocular lenses after explantation:A laboratory study. BMC Ophthalmol. 2015;15:170. doi: 10.1186/s12886-015-0149-1. doi:10.1186/s12886-015-0149-1. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 130.MacLean KD, Apel A, Wilson J, Werner L. Calcification of hydrophilic acrylic intraocular lenses associated with intracameral air injection following DMEK. J Cataract Refract Surg. 2015;41:1310–4. doi: 10.1016/j.jcrs.2015.05.006. [DOI] [PubMed] [Google Scholar]
- 131.Norouzpour A, Zarei-Ghanavati S. Hydrophilic acrylic intraocular lens opacification after Descemet stripping automated endothelial keratoplasty. J Ophthalmic Vis Res. 2016;11:225–7. doi: 10.4103/2008-322X.158897. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 132.Park JC, Habib NE, Moate RM. Intraocular lens opacification after corneal endothelial keratoplasty:Electron microscopy and x-ray element spectroscopy analysis. J Cataract Refract Surg. 2015;41:140–5. doi: 10.1016/j.jcrs.2014.05.035. [DOI] [PubMed] [Google Scholar]
- 133.Avetisov SE, Gamidov AA, Novikov IA, Fedorov AA, Kas'yanov AA. [Chemical microanalysis of mineral deposits on explanted hydrophilic acrylic intraocular lenses] Vestn Oftalmol. 2015;131:74–8. doi: 10.17116/oftalma2015131474-78. [DOI] [PubMed] [Google Scholar]
- 134.Morgan-Warren PJ, Andreatta W, Patel AK. Opacification of hydrophilic intraocular lenses after Descemet stripping automated endothelial keratoplasty. Clin Ophthalmol. 2015;9:277–83. doi: 10.2147/OPTH.S78930. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 135.Schrittenlocher S, Penier M, Schaub F, Bock F, Cursiefen C, Bachmann B. Intraocular lens calcifications after (Triple-) Descemet membrane endothelial keratoplasty. Am J Ophthalmol. 2017;179:129–36. doi: 10.1016/j.ajo.2017.04.024. [DOI] [PubMed] [Google Scholar]
- 136.Ham L, Balachandran C, Verschoor CA, van der Wees J, Melles GRJ. Visual rehabilitation rate after isolated Descemet membrane transplantation:Descemet membrane endothelial keratoplasty. Arch Ophthalmol. 2009;127:252–5. doi: 10.1001/archophthalmol.2008.619. [DOI] [PubMed] [Google Scholar]
- 137.Ham L, van Luijk C, Dapena I, Wong TH, Birbal R, van der Wees J, et al. Endothelial cell density after Descemet membrane endothelial keratoplasty:1- to 2-year follow-up. Am J Ophthalmol. 2009;148:521–7. doi: 10.1016/j.ajo.2009.04.025. [DOI] [PubMed] [Google Scholar]
- 138.Price MO, Giebel AW, Fairchild KM, Price FW. Descemet's membrane endothelial keratoplasty:Prospective multicenter study of visual and refractive outcomes and endothelial survival. Ophthalmology. 2009;116:2361–8. doi: 10.1016/j.ophtha.2009.07.010. [DOI] [PubMed] [Google Scholar]
- 139.Baydoun L, Tong CM, Tse WW, Chi H, Parker J, Ham L, et al. Endothelial cell density after Descemet membrane endothelial keratoplasty:1 to 5-year follow-up. Am J Ophthalmol. 2012;154:762–3. doi: 10.1016/j.ajo.2012.06.025. [DOI] [PubMed] [Google Scholar]
- 140.Dapena I, Ham L, Melles GRJ. Endothelial keratoplasty:DSEK/DSAEK or DMEK--the thinner the better?Curr Opin Ophthalmol. 2009;20:299–307. doi: 10.1097/ICU.0b013e32832b8d18. [DOI] [PubMed] [Google Scholar]
- 141.Sorkin N, Trinh T, Einan-Lifshitz A, Mednick Z, Santaella G, Telli A, et al. Outcomes of femtosecond laser-assisted Descemet membrane endothelial keratoplasty for failed penetrating keratoplasty. Can J Ophthalmol. 2019;54:741–5. doi: 10.1016/j.jcjo.2019.04.003. [DOI] [PubMed] [Google Scholar]
- 142.Shilova NF, Nahum Y, Adler A, Bahar I, Malyugin BE, Anisimova NS, et al. Comparative analysis of biomechanical parameters of the corneas following Descemet membrane endothelial keratoplasty and contralateral healthy corneas. Graefes Arch Clin Exp Ophthalmol. 2019;257:1925–9. doi: 10.1007/s00417-019-04387-y. [DOI] [PubMed] [Google Scholar]
- 143.Rudolph M, Laaser K, Bachmann BO, Cursiefen C, Epstein D, Kruse FE. Corneal higher-order aberrations after Descemet's membrane endothelial keratoplasty. Ophthalmology. 2012;119:528–35. doi: 10.1016/j.ophtha.2011.08.034. [DOI] [PubMed] [Google Scholar]
- 144.Ham L, Dapena I, van Luijk C, van der Wees J, Melles GRJ. Descemet membrane endothelial keratoplasty (DMEK) for Fuchs endothelial dystrophy:Review of the first 50 consecutive cases. Eye (Lond) 2009;23:1990–8. doi: 10.1038/eye.2008.393. [DOI] [PubMed] [Google Scholar]
- 145.Zwingelberg SB, Büscher F, Schrittenlocher S, Rokohl AC, Loreck N, Wawer-Matos P, et al. Long-term outcome of Descemet membrane endothelial keratoplasty in eyes with fuchs endothelial corneal dystrophy versus pseudophakic bullous keratopathy. Cornea. 2022;41:304–9. doi: 10.1097/ICO.0000000000002737. [DOI] [PubMed] [Google Scholar]
- 146.Cabrerizo J, Livny E, Musa FU, Leeuwenburgh P, van Dijk K, Melles GRJ. Changes in color vision and contrast sensitivity after Descemet membrane endothelial keratoplasty for fuchs endothelial dystrophy. Cornea. 2014;33:1010–5. doi: 10.1097/ICO.0000000000000216. [DOI] [PubMed] [Google Scholar]
- 147.Schoenberg ED, Price FW, Miller J, McKee Y, Price MO. Refractive outcomes of Descemet membrane endothelial keratoplasty triple procedures (combined with cataract surgery) J Cataract Refract Surg. 2015;41:1182–9. doi: 10.1016/j.jcrs.2014.09.042. [DOI] [PubMed] [Google Scholar]
- 148.Laaser K, Bachmann BO, Horn FK, Cursiefen C, Kruse FE. Descemet membrane endothelial keratoplasty combined with phacoemulsification and intraocular lens implantation:Advanced triple procedure. Am J Ophthalmol. 2012;154:47–55.e2. doi: 10.1016/j.ajo.2012.01.020. [DOI] [PubMed] [Google Scholar]
- 149.Bhandari V, Reddy JK, Siddharthan KS, Singhania N. Simultaneous Descemet's membrane endothelial keratoplasty and posterior iris-claw-fixated intra ocular lens implantation (IOL) in management of aphakic bullous keratopathy. Int Ophthalmol. 2016;36:305–11. doi: 10.1007/s10792-015-0117-z. [DOI] [PubMed] [Google Scholar]
- 150.Koçluk Y, Kasım B. Descemet membrane endothelial keratoplasty and intraocular lens implantation in cases of aphakic bullous keratopathy. Semin Ophthalmol. 2020;35:86–93. doi: 10.1080/08820538.2020.1733031. [DOI] [PubMed] [Google Scholar]
- 151.Gonnermann J, Maier A-KB, Klamann MKJ, Brockmann T, Bertelmann E, Joussen AM, et al. Posterior iris-claw aphakic intraocular lens implantation and Descemet membrane endothelial keratoplasty. Br J Ophthalmol. 2014;98:1291–5. doi: 10.1136/bjophthalmol-2014-304948. [DOI] [PubMed] [Google Scholar]
- 152.Quilendrino R, Yeh R-Y, Dapena I, Ham L, Dirisamer M, van Niekerk J, et al. Large diameter Descemet membrane endothelial keratoplasty in buphthalmic eyes. Cornea. 2013;32:e74–78. doi: 10.1097/ICO.0b013e3182765128. [DOI] [PubMed] [Google Scholar]
- 153.Einan-Lifshitz A, Belkin A, Sorkin N, Mednick Z, Boutin T, Gill I, et al. Descemet membrane endothelial keratoplasty after penetrating keratoplasty:Features for success. Cornea. 2018;37:1093–7. doi: 10.1097/ICO.0000000000001628. [DOI] [PubMed] [Google Scholar]
- 154.Price MO, Feng MT, McKee Y, Price FW. Repeat Descemet membrane endothelial keratoplasty:Secondary grafts with early intervention are comparable with fellow-eye primary grafts. Ophthalmology. 2015;122:1639–44. doi: 10.1016/j.ophtha.2015.04.037. [DOI] [PubMed] [Google Scholar]
- 155.Sorkin N, Mednick Z, Einan-Lifshitz A, Trinh T, Santaella G, Telli A, et al. Three-year outcome comparison between femtosecond laser-assisted and manual Descemet membrane endothelial keratoplasty. Cornea. 2019;38:812–6. doi: 10.1097/ICO.0000000000001956. [DOI] [PubMed] [Google Scholar]
- 156.Lam FC, Baydoun L, Dirisamer M, Lie J, Dapena I, Melles GRJ. Hemi-Descemet membrane endothelial keratoplasty transplantation:A potential method for increasing the pool of endothelial graft tissue. JAMA Ophthalmol. 2014;132:1469–73. doi: 10.1001/jamaophthalmol.2014.3328. [DOI] [PubMed] [Google Scholar]
- 157.Gerber-Hollbach N, Parker J, Baydoun L, Liarakos VS, Ham L, Dapena I, et al. Preliminary outcome of hemi-Descemet membrane endothelial keratoplasty for Fuchs endothelial dystrophy. Br J Ophthalmol. 2016;100:1564–8. doi: 10.1136/bjophthalmol-2015-307783. [DOI] [PubMed] [Google Scholar]


